Developer docs
API playgroundTry for free, no card

Search company profiles

Health Canada

Full company profile

uuid00yoj4z

Namestring
Health Canada
Legal namestring
Health Canada
Websiteurl
canada.ca
Company typeenum
Public
Founded yearint
1919
Descriptiontext

Health Canada is a federal department of the Government of Canada, formally established in 1919 and headquartered in Ottawa, responsible for national health policy, health product regulation, food safety, and public health protection for the entire Canadian population of approximately 38 million residents. The department operates as Canada's sole national regulatory authority for pharmaceuticals, biologics, biosimilars, medical devices, natural health products, and food, with statutory powers under the Department of Health Act to grant market authorization through mechanisms including Notice of Compliance approvals, Priority Review for serious conditions, and conditional marketing authorization. Health Canada runs public-facing programs and services including the Canadian Dental Care Plan (CDCP), the Recalls and Safety Alerts system, Canada's Food Guide, and the Vaccines and Immunization portfolio, and enforces mandatory Front-of-Pack nutritional labeling on pre-packaged foods starting January 1, 2026.

The department's product portfolio spans regulatory functions (drug and device approvals, clinical trial application reviews, food additive and supplement regulation jointly administered with the Canadian Food Inspection Agency) and direct public services (dental coverage, recalls, vaccination guidance). Health Canada does not sell commercial products or services; it is funded through annual parliamentary appropriations rather than commercial revenue. The department coordinates with 13 provinces and territories to implement national health policies, and engages in cross-border regulatory cooperation with the U.S. FDA and global health organizations including CEPI on pandemic preparedness. Notable recent regulatory actions include approvals of Wegovy for MASH, Dupixent for COPD (the first new COPD treatment in over a decade), and AGAMREE for Duchenne Muscular Dystrophy via Priority Review.

Short descriptiontext

Health Canada is the federal department of the Government of Canada that regulates drugs, medical devices, food safety, and public health for the country's 38 million residents. It funds programs like the Canadian Dental Care Plan and enforces national standards through mandatory approvals, recalls, and labeling rules.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
10,001+
akta.pro rankint
HeadquartersOttawa, Canada
HQ citystring
Ottawa
HQ countrystring
Canada
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
health product regulation, drug approval services, food safety regulation, medical device licensing, public health services
Industry7 codes
PRIMARYBPAIAJAN
Health Regulation, Licensing & Compliance (Public Health)
SECONDARYHLAJACAA
Health Policy & Legislation Authorities
Healthcare & Life Sciences/Public Health, Government & Regulators/Health Policy, Regulation & Compliance Authorities
SECONDARYHLAJAMAE
Regulatory Compliance, Licensing & Enforcement (Public Health)
SECONDARYHLAJAHAM
Consent, Documentation & Certification (Records/Passports/Proof of Vaccination)
Healthcare & Life Sciences/Public Health, Government & Regulators/Immunization Programs & Vaccine Administration
SECONDARYHLAJAAAA
State/Provincial/Regional Health Departments
Healthcare & Life Sciences/Public Health, Government & Regulators/Public Health Agencies & Health Departments
SECONDARYHLAJADAC
Medical Device Regulators
Healthcare & Life Sciences/Public Health, Government & Regulators/Medicines & Healthcare Product Regulators (Drugs/Biologics/Devices)
SECONDARYBPAIAJAD
Immunization & Vaccination Programs Administration
NAICS code3 codes
  • Administration of Public Health Programs92312
  • Administration of Public Health Programs923120
  • Regulation, Licensing, and Inspection of Miscellaneous Commercial Sectors926150
SIC code1 code
  • Services-Health Services8000
Product category
Government Health Regulation
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales
GTM typeB2B and B2C
B2B and B2C
Offering typeServices
Services
Core offering1 text field

Health Canada is the federal department of the Government of Canada that regulates health products, including pharmaceuticals, biologics, biosimilars, medical devices, natural health products, and food. It issues drug and device approvals, conducts clinical trial application reviews, administers food safety and nutrition labelling rules jointly with the Canadian Food Inspection Agency, and delivers public health programs such as the Canadian Dental Care Plan, national vaccination services, and the Recalls and Safety Alerts system. All public-facing services are provided free of charge, funded through parliamentary appropriations.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Approximately 125,300 smoking-attributable deaths prevented through 2018 Tobacco and Vaping Products Act through 2060
+2 more records
Product overview1 text field

Health Canada operates as the federal department responsible for national health policy and regulation, offering a portfolio of public-facing services and regulatory functions. The Canadian Dental Care Plan (CDCP) provides dental coverage to eligible Canadians. The Recalls and Safety Alerts system protects consumers through product safety notifications. Canada's Food Guide delivers evidence-based nutritional guidance, while Front-of-Pack Labelling regulations require warnings on pre-packaged foods high in sodium, sugars, or saturated fat. Drug and Health Product Approvals evaluate and authorize pharmaceuticals, biologics, biosimilars, and medical devices through pathways including Priority Review and conditional marketing authorization. Vaccines and Immunization programs provide national vaccination services. Clinical Trial Applications enable investigational studies in Canada. Food Safety and Nutrition Regulations govern food additives, enzymes, and supplements jointly with the Canadian Food Inspection Agency.

Product and service8 records
1Canadian Dental Care Plan (CDCP)
CategoryGovernment service
Description

A federal dental coverage program providing eligible Canadians with access to oral health care services, with applications open to eligible residents.

2Recalls and Safety Alerts
CategoryRegulatory system
Description

A public-facing system for issuing recalls and safety alerts on consumer products, drugs, food items, and other health products to protect Canadians from hazardous goods.

3Canada's Food Guide
CategoryPublic health resource
Description

Official nutritional guidance providing evidence-based recommendations on healthy eating patterns and food choices for Canadians.

4Front-of-Pack Nutrition Labelling
CategoryRegulatory system
Description

Mandatory front-of-package warning symbols on pre-packaged foods exceeding thresholds for sodium, sugars, and saturated fat, enforced starting January 1, 2026.

5Drug and Health Product Approvals
CategoryRegulatory function
Description

Health Canada's regulatory approval system for pharmaceuticals, biologics, biosimilars, medical devices, and other health products, including Priority Review and conditional marketing authorization pathways.

6Vaccines and Immunization
CategoryPublic health service
Description

National vaccination programs and immunization services providing Canadians with access to vaccines and public health guidance on vaccine-preventable diseases.

7Clinical Trial Applications
CategoryRegulatory function
Description

Health Canada's acceptance and review process for clinical trial applications (CTAs), enabling activation of clinical sites and evaluation of investigational therapies in Canada.

8Food Safety and Nutrition Regulations
CategoryRegulatory function
Description

Regulatory oversight of food additives, enzymes, supplements, and labelling requirements administered jointly with the Canadian Food Inspection Agency (CFIA), including updates consolidated into a flexible category system.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-08-05
Description

CEPI has pledged up to $50 million in funding to support Moderna's Phase 1 trial of mRNA-1469, an experimental mRNA vaccine targeting the Bundibugyo ebolavirus strain. The partnership enables clinical trials at three Canadian sites with approximately 80 healthy adults, demonstrating Health Canada's collaboration with global health organizations on pandemic preparedness.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2025-12-23
Description

Health Canada accepted Coya Therapeutics' Clinical Trial Application (CTA) for COYA 302 to treat amyotrophic lateral sclerosis (ALS), enabling activation of Canadian clinical sites for the ALSTARS Phase 2 trial. This collaboration enhances patient recruitment alongside existing U.S. clinical sites.

3Federal Minister of Health
Strategic tierCoreTypeOthersAnnounced on2025-10-22
Description

Federal Minister of Health Marjorie Michel announced a $10 million investment through the Youth Mental Health Fund to expand Integrated Youth Services (IYS) in Alberta, demonstrating ministerial oversight of Health Canada's funded initiatives. The YMHF represents Canada's $500 million investment in youth mental health over five years.

newswire.ca
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-05-07
Description

Health Canada coordinated with the FDA on a joint recall response for Jumbo Pumpkin Seeds sold by Ontario-based Advantage Health Matters due to salmonella contamination risk. The cross-border regulatory collaboration enabled synchronized public health notifications across Canada and U.S. states.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Health Canada and CFIA jointly introduced regulatory updates to Canada's food additives, enzymes, supplements and labelling requirements that took effect in late 2025 and early 2026, including mandatory front-of-package nutritional symbols for prepackaged foods.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
1Pharmaceuticals and Medical Devices Agency (PMDA)
TypeDirect peer
Description

Japan's regulatory agency for pharmaceuticals and medical devices. Comparable in mandate to Health Canada, with similar pathways for novel and biosimilar approvals and serves as an Asia-Pacific benchmark.

TypeDirect peer
Description

Swiss regulatory authority for therapeutic products. Operates similar drug and medical device licensing functions and is a recognized peer in international regulatory cooperation forums.

TypeDirect peer
Description

India's national regulatory body for pharmaceuticals and medical devices. Serves as a major global comparator for emerging market regulatory authority and increasingly engages with Health Canada on parallel approvals.

TypeDirect peer
Description

U.S. federal health regulatory authority responsible for drug approvals, medical device clearance, food safety, and public health oversight. Health Canada and the FDA already coordinate on cross-border recalls and share similar regulatory frameworks, making it the closest direct peer.

TypeDirect peer
Description

Australia's regulator for therapeutic goods including prescription medicines, medical devices, and vaccines. Operates comparable approval pathways and is part of similar international regulatory reliance initiatives.

TypeDirect peer
Description

EU agency responsible for scientific evaluation and supervision of medicines. Operates similar drug and biologic approval pathways to Health Canada and is a primary comparator for regulatory throughput and pathway design.

TypeDirect peer
Description

UK regulatory authority for medicines, medical devices, and blood components. Comparable in mandate and scale to Health Canada, frequently used as a benchmark for review timelines and post-Brexit regulatory collaboration.

TypeEmerging player
Description

Singapore's regulator for health products including pharmaceuticals, medical devices, and complementary medicines. Comparable in scope to Health Canada with a focus on becoming a regional regulatory hub.

TypeEmerging player
Description

Irish regulator for medicines, medical devices, and cosmetics. Similar mandate though smaller scale; participates in EU regulatory networks while maintaining national authority comparable to Health Canada.

TypeBroad incumbent
Description

Canadian federal agency responsible for public health, disease prevention, and emergency response. Adjacent to Health Canada's mandate, with overlapping immunization and health emergency responsibilities domestically.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks4 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Health Canada

Government Health Regulationcanada.ca

Health Canada is the federal department of the Government of Canada that regulates drugs, medical devices, food safety, and public health for the country's 38 million residents. It funds programs like the Canadian Dental Care Plan and enforces national standards through mandatory approvals, recalls, and labeling rules.

What Health Canada does

Health Canada is a federal department of the Government of Canada, formally established in 1919 and headquartered in Ottawa, responsible for national health policy, health product regulation, food safety, and public health protection for the entire Canadian population of approximately 38 million residents. The department operates as Canada's sole national regulatory authority for pharmaceuticals, biologics, biosimilars, medical devices, natural health products, and food, with statutory powers under the Department of Health Act to grant market authorization through mechanisms including Notice of Compliance approvals, Priority Review for serious conditions, and conditional marketing authorization. Health Canada runs public-facing programs and services including the Canadian Dental Care Plan (CDCP), the Recalls and Safety Alerts system, Canada's Food Guide, and the Vaccines and Immunization portfolio, and enforces mandatory Front-of-Pack nutritional labeling on pre-packaged foods starting January 1, 2026.

The department's product portfolio spans regulatory functions (drug and device approvals, clinical trial application reviews, food additive and supplement regulation jointly administered with the Canadian Food Inspection Agency) and direct public services (dental coverage, recalls, vaccination guidance). Health Canada does not sell commercial products or services; it is funded through annual parliamentary appropriations rather than commercial revenue. The department coordinates with 13 provinces and territories to implement national health policies, and engages in cross-border regulatory cooperation with the U.S. FDA and global health organizations including CEPI on pandemic preparedness. Notable recent regulatory actions include approvals of Wegovy for MASH, Dupixent for COPD (the first new COPD treatment in over a decade), and AGAMREE for Duchenne Muscular Dystrophy via Priority Review.

Health Canada firmographics

Firmographics
Name
Health Canada
Legal name
Health Canada
Website
https://canada.ca
Company type
Public
Founded year
1919
Operating status
Operating
Headcount range
10,001+ employees
Short description
Health Canada is the federal department of the Government of Canada that regulates drugs, medical devices, food safety, and public health for the country's 38 million residents. It funds programs like the Canadian Dental Care Plan and enforces national standards through mandatory approvals, recalls, and labeling rules.
Ownership category
akta.pro rank

Health Canada industry classification

Industry
Product category
Government Health Regulation
NAICS
Administration of Public Health Programs (92312), Administration of Public Health Programs (923120), Regulation, Licensing, and Inspection of Miscellaneous Commercial Sectors (926150)
SIC
Services-Health Services (8000)
akta.pro industry
PRIMARYBPAIAJAN
Health Regulation, Licensing & Compliance (Public Health)
SECONDARYHLAJACAA
Health Policy & Legislation Authorities
Healthcare & Life Sciences/Public Health, Government & Regulators/Health Policy, Regulation & Compliance Authorities
SECONDARYHLAJAMAE
Regulatory Compliance, Licensing & Enforcement (Public Health)
SECONDARYHLAJAHAM
Consent, Documentation & Certification (Records/Passports/Proof of Vaccination)
Healthcare & Life Sciences/Public Health, Government & Regulators/Immunization Programs & Vaccine Administration
SECONDARYHLAJAAAA
State/Provincial/Regional Health Departments
Healthcare & Life Sciences/Public Health, Government & Regulators/Public Health Agencies & Health Departments
SECONDARYHLAJADAC
Medical Device Regulators
Healthcare & Life Sciences/Public Health, Government & Regulators/Medicines & Healthcare Product Regulators (Drugs/Biologics/Devices)
SECONDARYBPAIAJAD
Immunization & Vaccination Programs Administration

Keywords

  • Health product regulation
  • Drug approval services
  • Food safety regulation
  • Medical device licensing
  • Public health services

Where Health Canada is headquartered

Location

Headquarters

HQ city
Ottawa
HQ country
Canada
HQ region
North America

Offices1 record

Markets served

Health Canada business model

Business model
GTM type
B2B and B2C
Offering type
Services
Cost components
Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales

Distribution channels1 record

Marketing channels4 records

Health Canada product offering

Product offering

Core offering

Health Canada is the federal department of the Government of Canada that regulates health products, including pharmaceuticals, biologics, biosimilars, medical devices, natural health products, and food. It issues drug and device approvals, conducts clinical trial application reviews, administers food safety and nutrition labelling rules jointly with the Canadian Food Inspection Agency, and delivers public health programs such as the Canadian Dental Care Plan, national vaccination services, and the Recalls and Safety Alerts system. All public-facing services are provided free of charge, funded through parliamentary appropriations.

Product overview

Health Canada operates as the federal department responsible for national health policy and regulation, offering a portfolio of public-facing services and regulatory functions. The Canadian Dental Care Plan (CDCP) provides dental coverage to eligible Canadians. The Recalls and Safety Alerts system protects consumers through product safety notifications. Canada's Food Guide delivers evidence-based nutritional guidance, while Front-of-Pack Labelling regulations require warnings on pre-packaged foods high in sodium, sugars, or saturated fat. Drug and Health Product Approvals evaluate and authorize pharmaceuticals, biologics, biosimilars, and medical devices through pathways including Priority Review and conditional marketing authorization. Vaccines and Immunization programs provide national vaccination services. Clinical Trial Applications enable investigational studies in Canada. Food Safety and Nutrition Regulations govern food additives, enzymes, and supplements jointly with the Canadian Food Inspection Agency.

Differentiator

Problem solved

Functional benefit

Products and services

  • Canadian Dental Care Plan (CDCP) A federal dental coverage program providing eligible Canadians with access to oral health care services, with applications open to eligible residents.
  • Recalls and Safety Alerts A public-facing system for issuing recalls and safety alerts on consumer products, drugs, food items, and other health products to protect Canadians from hazardous goods.
  • Canada's Food Guide Official nutritional guidance providing evidence-based recommendations on healthy eating patterns and food choices for Canadians.
  • Front-of-Pack Nutrition Labelling Mandatory front-of-package warning symbols on pre-packaged foods exceeding thresholds for sodium, sugars, and saturated fat, enforced starting January 1, 2026.
  • Drug and Health Product Approvals Health Canada's regulatory approval system for pharmaceuticals, biologics, biosimilars, medical devices, and other health products, including Priority Review and conditional marketing authorization pathways.
  • Vaccines and Immunization National vaccination programs and immunization services providing Canadians with access to vaccines and public health guidance on vaccine-preventable diseases.
  • Clinical Trial Applications Health Canada's acceptance and review process for clinical trial applications (CTAs), enabling activation of clinical sites and evaluation of investigational therapies in Canada.
  • Food Safety and Nutrition Regulations Regulatory oversight of food additives, enzymes, supplements, and labelling requirements administered jointly with the Canadian Food Inspection Agency (CFIA), including updates consolidated into a flexible category system.

Quantifiable outcome

  • Approximately 125,300 smoking-attributable deaths prevented through 2018 Tobacco and Vaping Products Act through 2060
  • +2 more outcomes

Companies that use Health Canada

Customer profile

Segments4 records

Ideal customer profiles4 records

Health Canada technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Health Canada partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered core and minor.

  • CEPI (Coalition for Epidemic Preparedness Innovations)coreStrategic or Co-development Partner · 5 August 2026CEPI has pledged up to $50 million in funding to support Moderna's Phase 1 trial of mRNA-1469, an experimental mRNA vaccine targeting the Bundibugyo ebolavirus strain. The partnership enables clinical trials at three Canadian sites with approximately 80 healthy adults, demonstrating Health Canada's collaboration with global health organizations on pandemic preparedness.
  • Coya TherapeuticsminorStrategic or Co-development Partner · 23 December 2025Health Canada accepted Coya Therapeutics' Clinical Trial Application (CTA) for COYA 302 to treat amyotrophic lateral sclerosis (ALS), enabling activation of Canadian clinical sites for the ALSTARS Phase 2 trial. This collaboration enhances patient recruitment alongside existing U.S. clinical sites.
  • Federal Minister of HealthcoreOthers · 22 October 2025Federal Minister of Health Marjorie Michel announced a $10 million investment through the Youth Mental Health Fund to expand Integrated Youth Services (IYS) in Alberta, demonstrating ministerial oversight of Health Canada's funded initiatives. The YMHF represents Canada's $500 million investment in youth mental health over five years.
  • U.S. Food and Drug Administration (FDA)coreStrategic or Co-development Partner · 7 May 2025Health Canada coordinated with the FDA on a joint recall response for Jumbo Pumpkin Seeds sold by Ontario-based Advantage Health Matters due to salmonella contamination risk. The cross-border regulatory collaboration enabled synchronized public health notifications across Canada and U.S. states.
  • Canadian Food Inspection Agency (CFIA)coreStrategic or Co-development PartnerHealth Canada and CFIA jointly introduced regulatory updates to Canada's food additives, enzymes, supplements and labelling requirements that took effect in late 2025 and early 2026, including mandatory front-of-package nutritional symbols for prepackaged foods.

Scale indicators2 records

Recent moves6 records

Expansion highlights6 records

Health Canada competitors and assessment

Company assessment

Direct peers

  • Pharmaceuticals and Medical Devices Agency (PMDA): Japan's regulatory agency for pharmaceuticals and medical devices. Comparable in mandate to Health Canada, with similar pathways for novel and biosimilar approvals and serves as an Asia-Pacific benchmark.
  • Swissmedic: Swiss regulatory authority for therapeutic products. Operates similar drug and medical device licensing functions and is a recognized peer in international regulatory cooperation forums.
  • Central Drugs Standard Control Organisation (CDSCO): India's national regulatory body for pharmaceuticals and medical devices. Serves as a major global comparator for emerging market regulatory authority and increasingly engages with Health Canada on parallel approvals.
  • U.S. Food and Drug Administration (FDA): U.S. federal health regulatory authority responsible for drug approvals, medical device clearance, food safety, and public health oversight. Health Canada and the FDA already coordinate on cross-border recalls and share similar regulatory frameworks, making it the closest direct peer.
  • Therapeutic Goods Administration (TGA): Australia's regulator for therapeutic goods including prescription medicines, medical devices, and vaccines. Operates comparable approval pathways and is part of similar international regulatory reliance initiatives.
  • European Medicines Agency (EMA): EU agency responsible for scientific evaluation and supervision of medicines. Operates similar drug and biologic approval pathways to Health Canada and is a primary comparator for regulatory throughput and pathway design.
  • Medicines and Healthcare products Regulatory Agency (MHRA): UK regulatory authority for medicines, medical devices, and blood components. Comparable in mandate and scale to Health Canada, frequently used as a benchmark for review timelines and post-Brexit regulatory collaboration.

Emerging players

  • Health Sciences Authority (HSA): Singapore's regulator for health products including pharmaceuticals, medical devices, and complementary medicines. Comparable in scope to Health Canada with a focus on becoming a regional regulatory hub.
  • Health Products Regulatory Authority (HPRA): Irish regulator for medicines, medical devices, and cosmetics. Similar mandate though smaller scale; participates in EU regulatory networks while maintaining national authority comparable to Health Canada.

Broad incumbents

  • Public Health Agency of Canada (PHAC): Canadian federal agency responsible for public health, disease prevention, and emergency response. Adjacent to Health Canada's mandate, with overlapping immunization and health emergency responsibilities domestically.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks4 records

Key highlights6 records

Customer concentration

Health Canada social profiles

Digital presence

Health Canada financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Health Canada leadership team

Management profile

Number of profiles

Profiles1 record

Health Canada funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Health Canada M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Health Canada

What does Health Canada do?

Health Canada is the federal department of the Government of Canada that regulates health products, including pharmaceuticals, biologics, biosimilars, medical devices, natural health products, and food. It issues drug and device approvals, conducts clinical trial application reviews, administers food safety and nutrition labelling rules jointly with the Canadian Food Inspection Agency, and delivers public health programs such as the Canadian Dental Care Plan, national vaccination services, and the Recalls and Safety Alerts system. All public-facing services are provided free of charge, funded through parliamentary appropriations.

Is Health Canada a public or private company?

Health Canada is a public company. It is classified as state government owned and is currently operating.

When was Health Canada founded?

Health Canada was founded in 1919. It employs 10,001+ people.

Where is Health Canada based?

Health Canada is headquartered in Ottawa, Canada, in the North America region.

Who are Health Canada's main competitors?

Direct peers on record are Pharmaceuticals and Medical Devices Agency (PMDA), Swissmedic, Central Drugs Standard Control Organisation (CDSCO), U.S. Food and Drug Administration (FDA), Therapeutic Goods Administration (TGA), European Medicines Agency (EMA) and Medicines and Healthcare products Regulatory Agency (MHRA). Emerging players are Health Sciences Authority (HSA) and Health Products Regulatory Authority (HPRA). Public Health Agency of Canada (PHAC) is listed as a broad incumbent.

Does Health Canada have an API?

No public API is recorded for Health Canada.

What industry is Health Canada in?

Health Canada's product category is Government Health Regulation. Its primary akta.pro industry code is BPAIAJAN, Health Regulation, Licensing & Compliance (Public Health), with a secondary code of HLAJACAA, Health Policy & Legislation Authorities. Its NAICS code is 92312 and its SIC code is 8000.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Defense WorldAbbVie (NYSE:ABBV) Reaches New 12-Month High – What’s Next?AbbVie shares reached a new 52-week high of $268.41 on Wednesday, trading at $266.45. The stock's positive sentiment is driven by Health Canada's approval of EPKINLY for follicular lymphoma, an AI drug-discovery partnership with Iambic, and European approval of Rinvoq for pediatric arthritis. Analysts have a consensus 'Moderate Buy' rating with an average target price of $276.64.FinancialContent Business PageHealth Canada Clears Updated Clinical Trial Protocol for Redsenol-1 PlusHealth Canada cleared the updated clinical trial protocol for Redsenol-1 Plus, an investigational ginsenoside supplement for cancer-related fatigue. The company has no objection to the revised study framework, allowing the trial to continue. The study, registered on ClinicalTrials.gov, aims to further explore the product's potential in cancer supportive care.FinancialContent Business PageFujirebio Expands Access in Canada to Blood-based Neurology Testing with Health Canada Class II Medical Device Licenses for the Lumipulse® G NfL Blood and Lumipulse G pTau 217 Plasma AssaysHealth Canada issued Class II Medical Device Licenses for Fujirebio's Lumipulse G NfL Blood and Lumipulse G pTau 217 Plasma assays for use on the LUMIPULSE G platform in Canada. The approvals expand access to blood-based biomarkers for neurological disease, including Alzheimer's detection in patients aged 50 and older.EdmontonjournalA cross-country road trip uncovered a booming illicit nicotine pouch marketA nicotine users' rights group, Rights 4 Vapers, bought 148 illegal nicotine products from 42 retailers across five provinces during a nine-day summer tour, finding illicit pouches as concentrated as 50 mg. The group blames the government's 2024 ministerial order, which approved only Zonnic, for fueling the black market. Health Canada denies the order drove illicit activity.The National Law ReviewHealth Canada Begins Consultation on Proposed Food Packaging FramHealth Canada has opened a public consultation on a proposed mandatory notification framework for food contact materials, requiring manufacturers, importers or retailers to submit chemical composition and distribution data through an online portal. Comments are due October 9, 2026, with a second consultation expected November 2026 to January 2027. Health Canada proposes a roughly five-year phase-in period.Winnipeg Free PressDonating plasma for good reasons – Winnipeg Free PressGrifols paused plasma collections at its Winnipeg locations following the deaths of two donors, prompting Health Canada to issue a non-compliance order regarding alarm monitoring procedures. This incident has reignited public debate over the safety and ethics of the for-profit plasma donation system in Canada, despite health authorities stating the deaths were not linked to the donations.Local Breaking'Unusual' fentanyl seized in Pictou County, man chargedRCMP officers in Pictou County, Nova Scotia, seized over 50 grams of unusual fentanyl products believed to have been purchased on the dark web and arrested 35-year-old Jake Bruce Murphy for possession with intent to traffic. The seized substances exhibited uncommon physical characteristics, such as black clay-like textures and pink chunks, prompting further confirmation testing by Health Canada. Murphy remains in custody pending future court appearances.The Globe and MailWhat we know so far about Grifols’s plasma pause and Health Canada’s safety concernsGrifols has temporarily halted plasma collection at its Canadian centres following a formal notice of non-compliance from Health Canada regarding safety deficiencies. This regulatory action follows public scrutiny and the deaths of two donors, prompting an investigation into operational failures such as inadequate staff training and improper response to medical alarms.DiscoverairdrieHealth Canada weighs lithium-ion battery rulesHealth Canada is reviewing feedback from a consultation on proposed mandatory safety requirements for lithium-ion batteries in consumer products, citing hundreds of reported incidents and fatalities between 2013 and 2023. The initiative aims to address risks from uncertified or poorly manufactured batteries but explicitly excludes e-bikes and e-scooters, which are regulated as vehicles under separate legislation. CSA Group emphasized that safety standards must be evaluated at both the battery and finished-product levels to ensure comprehensive protection against hazards like thermal runaway.SupplysidesjHealth Canada establishes prebiotic monographHealth Canada has published a new monograph on prebiotics, establishing a regulatory framework that reclassifies prebiotic fibers from Class III to Class I to streamline approvals for natural health products. The Global Prebiotic Association collaborated with Health Canada’s Natural and Non-prescription Health Products Directorate during the multi-year development of this science-backed guidance. This change is expected to reduce time-to-market for supplement manufacturers while validating the category through stringent Canadian standards.